Pollack G M, Brouwer K L
Division of Pharmaceutics, School of Pharmacy, University of North Carolina, Chapel Hill 27599-7360.
J Pharmacokinet Biopharm. 1991 Apr;19(2):189-225. doi: 10.1007/BF01073869.
The potential influence of alterations in several physiologic processes (hepatocellular egress, biliary excretion, gastrointestinal transit) and biotransformation steps (oxidative metabolism, glucuronidation) on the disposition of agents subject to significant enterohepatic recirculation (ER) via the glucuronide conjugate was examined in a series of simulation experiments. The model of ER developed was based upon the disposition of valproic acid (VPA) and valproate glucuronide (VPA-G) in the rat. The systemic disposition of VPA was simulated following changes in several processes contributing to (or competing with) ER: hepatic oxidative metabolism, hepatic glucuronidation, sinusoidal egress of glucuronide conjugate, canalicular egress of glucuronide conjugate, and gastrointestinal transit. Changes in the formation clearance of VPA-G resulted in a less than proportional change in systemic clearance of VPA, whereas changes in oxidative metabolism led to a greater than proportional change in systemic clearance. Furthermore, alterations in hepatocellular egress of VPA-G affected the disposition of the parent compound, suggesting that drug interactions or disease state effects on metabolite transport may be misinterpreted as effects at the level of metabolite formation. Analytical methods are proposed to recover the intrinsic kinetic parameters (formation clearances of metabolites, renal clearance of parent, volume of distribution) in the presence of ER from the systemic disposition of the parent alone.
在一系列模拟实验中,研究了几种生理过程(肝细胞输出、胆汁排泄、胃肠道转运)和生物转化步骤(氧化代谢、葡萄糖醛酸化)的改变对通过葡萄糖醛酸共轭物进行显著肠肝循环(ER)的药物处置的潜在影响。所建立的ER模型基于丙戊酸(VPA)和丙戊酸葡萄糖醛酸苷(VPA-G)在大鼠体内的处置情况。在几种有助于(或与)ER的过程发生变化后,模拟了VPA的全身处置情况:肝脏氧化代谢、肝脏葡萄糖醛酸化、葡萄糖醛酸共轭物的窦状隙输出、葡萄糖醛酸共轭物的胆小管输出以及胃肠道转运。VPA-G形成清除率的变化导致VPA全身清除率的变化小于比例变化,而氧化代谢的变化导致全身清除率的变化大于比例变化。此外,VPA-G肝细胞输出的改变影响了母体化合物的处置,这表明药物相互作用或疾病状态对代谢物转运的影响可能被误解为代谢物形成水平的影响。本文提出了一些分析方法,以便在存在ER的情况下,仅从母体的全身处置情况中恢复内在动力学参数(代谢物的形成清除率、母体的肾清除率、分布容积)。